Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTavistock Regulatory News (TAVI)

Share Price Information for Tavistock (TAVI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.25
Bid: 4.00
Ask: 4.50
Change: 0.00 (0.00%)
Spread: 0.50 (12.50%)
Open: 4.25
High: 4.25
Low: 4.25
Prev. Close: 4.25
TAVI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update And Entry Into Loan Facility

27 Sep 2019 07:00

RNS Number : 8763N
Tavistock Investments PLC
27 September 2019
 

Tavistock Investments Plc

("Tavistock" or the "Company")

Ticker: TAVI

TRADING UPDATE AND ENTRY INTO LOAN FACILITY

 

27  September 2019

 

Trading update

The Board is pleased to report that the Company is trading in line with market expectations, despite challenging market conditions caused by political instability, anxieties over BREXIT outcomes and international trade disputes.

It is impossible to determine how much more challenging conditions may become over the short term and any potential impact on the Company's future trading before more normal conditions return.

The Board continues to believe that it is in the best long-term interests of the Company to improve profitability through:

·; the selective purchases of client books from retiring advisers;

·; investment in initiatives designed to significantly improve inflows of FUM; and

·; reduction of net debt through scheduled capital repayments under its existing NatWest loan facility.

The Company's regulatory capital requirement has increased as a result of these initiatives. However, the Directors' believe that seeking to raise additional capital now would be unduly dilutive for shareholders. To bolster the regulatory capital position in a manner that is not dilutive to shareholders, they have entered into an unsecured convertible loan facility (the "Facility") with two of the Company's directors and its Chief Investment Officer.

The Facility

The Facility is for £630,000 and may be drawn down by the Company at any point within the next year. The Facility is unsecured and is being provided by two of the Company's directors, Oliver Cooke and Brian Raven, and by its Chief Investment Officer, Christopher Peel. Each of them has given an irrevocable undertaking to the Company that upon receipt of 30 days' notice and subject to compliance with regulatory obligations regarding close periods, they will provide up to £210,000 of loan capital to the Company on the following terms:

·; Facility fee 5% of the funds committed;

·; interest payable on funds drawn down of 10%;

·; the repayment of any sums drawn down, together with interest thereon, to be made on 30 September 2020;

·; the option for the Company only, at its absolute discretion, to elect to convert amounts drawn down, together with interest thereon, into new ordinary shares in the Company of 1p each, at a conversion price of 2p per share, being today's bid price; and

·; a non-utilisation fee payable, if appropriate, on 30 September 2020, equivalent to 3% of funds committed but not drawn down.

Related Party Transaction

The entry into the Facility by the Company with Oliver Cooke, Brian Raven and Christopher Peel constitute transactions with related parties under the AIM Rules for Companies. The independent Non-executive Directors of the Company, Roderic Rennison and Peter Dornan, having consulted with the Company's nominated Adviser, Arden Partners, consider that the terms of the transaction are fair and reasonable insofar as the Company's shareholders are concerned.

 

ENQUIRIES

Tavistock Investment plc

Oliver Cooke / Brian Raven +44 (0)1753 867000

Arden Partners plc - Nominated Adviser

Paul Shackleton +44 (0)20 7614 5900

Allenby Capital Limited - Broker

Nick Naylor / Nick Athanas +44 (0)20 3328 5656

Vested - PR Partner

Elspeth Rothwell +44 (0)20 3890 8118

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSEDFUMFUSESU
Date   Source Headline
12th Mar 20217:00 amRNSNotice of GM
11th Mar 20217:00 amRNSRescheduling of General Meeting
1st Mar 20217:00 amRNSNotice of GM
10th Feb 202112:01 pmRNSLetter to shareholders
9th Feb 20212:06 pmRNSSecond Price Monitoring Extn
9th Feb 20212:00 pmRNSPrice Monitoring Extension
9th Feb 20219:05 amRNSSecond Price Monitoring Extn
9th Feb 20219:00 amRNSPrice Monitoring Extension
9th Feb 20217:00 amRNSTrading Update
29th Jan 20217:00 amRNSDirector/PDMR Shareholding
28th Jan 20217:00 amRNSDirector/PDMR Shareholding
4th Dec 20207:00 amRNSPostponement of general meeting
20th Nov 20207:00 amRNSNotice of GM
10th Nov 20207:00 amRNSInterim Results
23rd Sep 202012:15 pmRNSResult of AGM & GM
14th Sep 20207:00 amRNSCorrection to no. of shares admitted to trading
9th Sep 20207:00 amRNSAppointment of Nominated Adviser & Rule 17 update
28th Aug 20207:00 amRNSNotice of AGM
23rd Jul 20209:07 amRNSFinal Results For Year Ended 31 March 2020
23rd Jul 20207:00 amRNSFinal Results For Year Ended 31 March 2020
24th Jun 20207:00 amRNSTrading Update
8th Apr 20207:00 amRNSTrading Update
19th Mar 202010:52 amRNSDirector/PDMR Shareholding
19th Mar 202010:01 amRNSDirector/PDMR Shareholding
19th Mar 20207:00 amRNSIssue of Shares to Strategic Investor
21st Nov 20197:00 amRNSInterim Results
1st Oct 20194:35 pmRNSDirector/PDMR Shareholding
30th Sep 201911:44 amRNSDirector/PDMR Shareholding
27th Sep 20196:09 pmRNSDirector/PDMR Shareholding
27th Sep 20197:00 amRNSTrading Update And Entry Into Loan Facility
25th Sep 20193:44 pmRNSResult of AGM
4th Sep 201912:11 pmRNSNotice of AGM
3rd Sep 20197:00 amRNSChange of Auditor
30th May 201911:49 amRNSTermination of Strategic Alliance with Lighthouse
15th May 20191:17 pmRNSPayment of Maiden Interim Dividend
15th May 20197:00 amRNSFinal Results
13th May 20197:00 amRNSNotice of results
9th May 20198:56 amRNSDirector/PDMR Shareholding
14th Feb 20197:00 amRNSPre-Close Trading Update
23rd Nov 20187:00 amRNSHolding(s) in Company
23rd Nov 20187:00 amRNSHolding(s) in Company
19th Nov 20185:47 pmRNSHolding(s) in Company
14th Nov 20187:30 amRNSResult of £1.25m Fundraise
14th Nov 20187:00 amRNSStrategic Alliance and Proposed Fundraise
8th Nov 20185:29 pmRNSCorrection to Interim Results
8th Nov 20187:00 amRNSInterim Results
1st Oct 20184:26 pmRNSHolding(s) in Company
26th Sep 201812:35 pmRNSResult of AGM
30th Aug 20181:10 pmRNSNotice of AGM
27th Jul 201812:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.